Monday , November 25 2024
Home / Mike Norman Economics / Rod Tucker PhD – Chloroquine in severe COVID-19: reviewing the evidence

Rod Tucker PhD – Chloroquine in severe COVID-19: reviewing the evidence

Summary:
At the beginning of treatment high dose Chloroquine seemed to save lives, but in later stages fatality rates went up. The trail in this experiment was halted early because of the dangers.  While this trial was interrupted at an early stage, the results should be seen as a warning that chloroquine (and probably hydroxychloroquine) are not the purported wonder drugs for those with COVID-19. Rod Tucker BPharm PhD  Chloroquine in severe COVID-19: reviewing the evidence

Topics:
Mike Norman considers the following as important:

This could be interesting, too:

Matias Vernengo writes Milei’s Psycho Shock Therapy

Bill Haskell writes Population Growth Outcomes

Robert Vienneau writes Books After Marx

Joel Eissenberg writes Undocumented labor: solutions, not scapegoating

At the beginning of treatment high dose Chloroquine seemed to save lives, but in later stages fatality rates went up. The trail in this experiment was halted early because of the dangers. 


While this trial was interrupted at an early stage, the results should be seen as a warning that chloroquine (and probably hydroxychloroquine) are not the purported wonder drugs for those with COVID-19.

Rod Tucker BPharm PhD 

Mike Norman
Mike Norman is an economist and veteran trader whose career has spanned over 30 years on Wall Street. He is a former member and trader on the CME, NYMEX, COMEX and NYFE and he managed money for one of the largest hedge funds and ran a prop trading desk for Credit Suisse.

Leave a Reply

Your email address will not be published. Required fields are marked *